{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T03:10:56Z","timestamp":1758597056225,"version":"3.44.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.suc.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T09:53:50Z","timestamp":1572342830000},"page":"91-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nonsurgical Management of Lymph Node Basins in Melanoma"],"prefix":"10.1016","volume":"100","author":[{"given":"Rogeh","family":"Habashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Francescutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.suc.2019.09.008_bib1","first-page":"215","article-title":"Malignant melanoma: prevention, early detection, and treatment in the 21st century","volume":"50","author":"Rigel","year":"2000","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 23","key":"10.1016\/j.suc.2019.09.008_bib2","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/cncr.29050","article-title":"Clinical and prognostic factors for melanoma of the skin using SEER registries: collaborative stage data collection system, version 1 and version 2","volume":"120","author":"Kosary","year":"2014","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.suc.2019.09.008_bib3","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":"Increasing burden of melanoma in the United States","volume":"129","author":"Linos","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"issue":"11","key":"10.1016\/j.suc.2019.09.008_bib4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1586\/era.10.170","article-title":"A\u00a0new understanding in the epidemiology of melanoma","volume":"10","author":"Erdei","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"10.1016\/j.suc.2019.09.008_bib5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.sla.0000086543.45557.cb","article-title":"Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases","volume":"238","author":"Morton","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2019.09.008_bib6","first-page":"872","article-title":"Melanotic cancerous disease","volume":"2","author":"Snow","year":"1892","journal-title":"Lancet"},{"key":"10.1016\/j.suc.2019.09.008_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJM197709222971202","article-title":"Inefficacy of immediate node dissection in stage I melanoma of the limbs","volume":"297","author":"Veronesi","year":"1977","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2019.09.008_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","article-title":"Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial","volume":"351","author":"Cascinelli","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.suc.2019.09.008_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","article-title":"Long term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0\u00a0mm)","volume":"7","author":"Balch","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2019.09.008_bib10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z","article-title":"A\u00a0prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma: preliminary results","volume":"41","author":"Sim","year":"1978","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.suc.2019.09.008_bib11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(195809\/10)11:5<1025::AID-CNCR2820110525>3.0.CO;2-3","article-title":"Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults","volume":"11","author":"Lane","year":"1958","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.suc.2019.09.008_bib12","first-page":"105","article-title":"The role of regional node dissection in the treatment of malignant melanoma","volume":"179","author":"Southwick","year":"1962","journal-title":"Arch Surg"},{"key":"10.1016\/j.suc.2019.09.008_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00000658-196507000-00003","article-title":"Malignant melanoma: a clinical study of 427 cases","volume":"162","author":"Mundth","year":"1965","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2019.09.008_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ijc.2910340204","article-title":"Occult melanoma in lymph nodes detected by antiserum to S-100 protein","volume":"34","author":"Cochran","year":"1984","journal-title":"Int J Cancer"},{"key":"10.1016\/j.suc.2019.09.008_bib15","first-page":"399","article-title":"Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies","volume":"78","author":"Cochran","year":"1987","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.suc.2019.09.008_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.suc.2019.09.008_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008390-199508000-00008","article-title":"Sentinel lymph node status as indicator of the presence of metastatic melanoma in regional lymph nodes","volume":"5","author":"Thompson","year":"1995","journal-title":"Melanoma Res"},{"key":"10.1016\/j.suc.2019.09.008_bib18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.suc.2019.09.008_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","article-title":"Sentinel-node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial","volume":"242","author":"Morton","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2019.09.008_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archsurg.140.9.865","article-title":"Melanoma recurrence patterns after negative selective lymphadenectomy","volume":"140","author":"Zogakis","year":"2005","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.suc.2019.09.008_bib21","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/jid.2014.452","article-title":"More people die from thin melanomas (1\u00a0mm) than from thick melanomas (> 4mm) in Queensland, Australia","volume":"135","author":"Whiteman","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.008_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1245\/ASO.2006.05.011","article-title":"Predictors or regional nodal disease in patients with thin melanomas","volume":"13","author":"Karakousis","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.suc.2019.09.008_bib23","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1245\/s10434-006-9319-y","article-title":"Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN staging biopsy in these patients","volume":"14","author":"Karakousis","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.008_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/SLA.0b013e3182306c72","article-title":"Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma","volume":"255","author":"Murali","year":"2012","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.suc.2019.09.008_bib25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1346-8138.2007.00323.x","article-title":"Sentinel lymph node biopsy in patients with thin melanomas","volume":"34","author":"Cecchi","year":"2007","journal-title":"J\u00a0Dermatol"},{"issue":"35","key":"10.1016\/j.suc.2019.09.008_bib26","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","article-title":"Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma","volume":"31","author":"Han","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.008_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/CMR.0b013e32833ba9ff","article-title":"Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma","volume":"20","author":"Kunte","year":"2010","journal-title":"Melanoma Res"},{"issue":"7","key":"10.1016\/j.suc.2019.09.008_bib29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jso.24743","article-title":"Predictors of false negative sentinel lymph node biopsy in trunk and extremity melanoma","volume":"116","author":"Sinnamon","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.008_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1245\/ASO.2003.06.007","article-title":"Sentinel lymph node biopsy for head and neck melanomas","volume":"10","author":"Chao","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.suc.2019.09.008_bib31","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.21873\/anticanres.13024","article-title":"Risk factors for regional and systemic metastases in patients with sentinel lymph node-negative melanoma","volume":"38","author":"Erdmann","year":"2018","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.suc.2019.09.008_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.ejso.2016.01.010","article-title":"Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions","volume":"42","author":"Rees","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.suc.2019.09.008_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jso.25324","article-title":"Follow-up of the melanoma patient","volume":"119","author":"Deschner","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"issue":"23","key":"10.1016\/j.suc.2019.09.008_bib34","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2019.09.008_bib35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cncr.21189","article-title":"Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma","volume":"104","author":"Wagner","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2019.09.008_bib36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archsurg.141.3.284","article-title":"Futility of fluoro-deoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma","volume":"141","author":"Clark","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.suc.2019.09.008_bib37","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2967\/jnumed.114.153643","article-title":"Results of a prospective multicenter International Atomic Energy Agency sentinel node trial on the value of SPECT\/CT over planar imaging in various malignancies","volume":"56","author":"Jimenez-Heffernan","year":"2015","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.suc.2019.09.008_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1200\/JCO.1988.6.1.163","article-title":"The role of elective lymph node dissection in melanoma: rationale, results, and controversies","volume":"6","author":"Balch","year":"1988","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2019.09.008_bib39","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1245\/ASO.2006.03.058","article-title":"Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study","volume":"13","author":"Wong","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2019.09.008_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1245\/s10434-009-0836-3","article-title":"Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy","volume":"17","author":"Kingham","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2019.09.008_bib41","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrclinonc.2010.100","article-title":"Importance of tumor load in the sentinel node in melanoma: clinical dilemmas","volume":"7","author":"Akkooi","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.suc.2019.09.008_bib42","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/bjs.8878","article-title":"Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection","volume":"99","author":"van der Ploeg","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.suc.2019.09.008_bib43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/CMR.0000000000000081","article-title":"Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node?","volume":"24","author":"Satzger","year":"2014","journal-title":"Melanoma Res"},{"key":"10.1016\/j.suc.2019.09.008_bib44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"issue":"15_suppl","key":"10.1016\/j.suc.2019.09.008_bib45","doi-asserted-by":"crossref","first-page":"9501","DOI":"10.1200\/JCO.2018.36.15_suppl.9501","article-title":"Final analysis of DeCOG-SLT trial: survival outcomes of complete lymph node dissection in melanoma patients with positive sentinel node","volume":"36","author":"Leiter","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2019.09.008_bib46","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0190-9622(99)70004-6","article-title":"Lymph node metastases of cutaneous melanoma: diagnosis by B-scan and color Doppler sonography","volume":"41","author":"Moehrle","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.suc.2019.09.008_bib47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2017.09.002","article-title":"Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria","volume":"87","author":"Madu","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.suc.2019.09.008_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2018.02.022","article-title":"Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations","volume":"96","author":"Verver","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.suc.2019.09.008_bib49","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1200\/JCO.2010.30.9567","article-title":"Non-sentinel node risk score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes","volume":"28","author":"Murali","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.suc.2019.09.008_bib50","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.suc.2019.09.008_bib51","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jso.25193","article-title":"A\u00a0model for predicting low probability of non-sentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node","volume":"118","author":"Bhutiani","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"12","key":"10.1016\/j.suc.2019.09.008_bib52","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1245\/s10434-018-6647-7","article-title":"Prediction of residual nodal disease at completion dissection following positive sentinel lymph node biopsy for melanoma","volume":"25","author":"Sinnamon","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.suc.2019.09.008_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11864-018-0575-4","article-title":"Sentinel lymph node biopsy and completion lymph node dissection for melanoma","volume":"19","author":"Masoud","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"12","key":"10.1016\/j.suc.2019.09.008_bib54","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1245\/s10434-010-1203-0","article-title":"The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)","volume":"17","author":"Faries","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.suc.2019.09.008_bib55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1245\/s10434-017-6242-3","article-title":"Morbidity and outcomes following axillary lymphadenectomy for melanoma: weighing the risk of surgery in the era of MSLT-II","volume":"25","author":"Postlewait","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2019.09.008_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/CMR.0b013e3283531335","article-title":"An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection","volume":"22","author":"Foote","year":"2012","journal-title":"Melanoma Res"},{"key":"10.1016\/j.suc.2019.09.008_bib57","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/cncr.10186","article-title":"A\u00a0phase II study of neoadjuvant biochemotherapy for stage III melanoma","volume":"94","author":"Gibbs","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2019.09.008_bib58","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2217\/imt.12.62","article-title":"A\u00a0neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes","volume":"4","author":"Kounalakis","year":"2012","journal-title":"Immunotherapy"},{"issue":"11","key":"10.1016\/j.suc.2019.09.008_bib59","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41591-018-0197-1","article-title":"Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma","volume":"24","author":"Amaria","year":"2018","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.suc.2019.09.008_bib60","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41591-018-0198-0","article-title":"Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma","volume":"24","author":"Blank","year":"2018","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.suc.2019.09.008_bib61","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/annonc\/mdy226","article-title":"Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma","volume":"29","author":"Tetzlaff","year":"2018","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.suc.2019.09.008_bib62","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.ejca.2014.06.009","article-title":"BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy","volume":"50","author":"Barbour","year":"2014","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.suc.2019.09.008_bib63","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1470-2045(17)30171-7","article-title":"Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pre-treated patients with advanced BRAFV600 mutant melanoma: an open-label, single arm, dual-center, phase 2 clinical trial","volume":"18","author":"Schreuer","year":"2017","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.008_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12253-017-0324-1","article-title":"Efficacy of vemurafenib treatment in 43 metastatic melanoma patients with BRAF mutation. single-institute retrospective analysis, early real-life survival data","volume":"25","author":"Czirbesz","year":"2019","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"10.1016\/j.suc.2019.09.008_bib65","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/jamaoncol.2016.4877","article-title":"Systemic therapy for previously untreated advanced braf-mutated melanoma: a systematic review and network meta-analysis of randomized clinical trials","volume":"3","author":"Devji","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.suc.2019.09.008_bib66","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1063::AID-CNCR17>3.0.CO;2-E","article-title":"Analysis of prognosis and disease progression after local recurrence of melanoma","volume":"88","author":"Dong","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2019.09.008_bib67","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/jso.24939","article-title":"Neoadjuvant systemic therapy for regionally advanced melanoma","volume":"117","author":"Jakub","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2019.09.008_bib68","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1418::AID-CNCR8>3.0.CO;2-A","article-title":"Outcomes of patients with local recurrence of cutaneous malignant melanoma","volume":"80","author":"Cohn-Cedermark","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2019.09.008_bib69","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/1097-0142(19850315)55:6<1398::AID-CNCR2820550639>3.0.CO;2-A","article-title":"The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma","volume":"55","author":"Urist","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2019.09.008_bib70","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00000637-200105000-00006","article-title":"Locally recurrent malignant melanoma characteristics and outcomes: a single institution study","volume":"46","author":"Wildemore","year":"2001","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.suc.2019.09.008_bib71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00000658-198307000-00013","article-title":"Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma","volume":"198","author":"Roses","year":"1988","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.suc.2019.09.008_bib72","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1245\/s10434-017-5883-6","article-title":"Sentinel lymph node biopsy for recurrent melanoma: a multicenter study","volume":"24","author":"Beasley","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.008_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jamcollsurg.2016.03.025","article-title":"Status of the regional nodal basin remains highly prognostic in melanoma patients with in-transit disease","volume":"223","author":"Gonzalez","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"issue":"1","key":"10.1016\/j.suc.2019.09.008_bib74","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","article-title":"Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma","volume":"21","author":"Gerami","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.suc.2019.09.008_bib75","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1080\/03007995.2016.1192997","article-title":"Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients","volume":"32","author":"Berger","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.suc.2019.09.008_bib76","first-page":"428","article-title":"Impact of a 31-gene expression profiling test for cutaneous melanoma on dermatologists\u2019 clinical management decisions","volume":"16","author":"Farberg","year":"2017","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.suc.2019.09.008_bib77","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1038\/ncomms10684","article-title":"Intraoperative intravital microscopy permits the study of human tumor vessels","volume":"7","author":"Fisher","year":"2016","journal-title":"Nat Commun"},{"issue":"28","key":"10.1016\/j.suc.2019.09.008_bib78","doi-asserted-by":"crossref","first-page":"20165","DOI":"10.18632\/oncotarget.24957","article-title":"Intravital microscopy in the study of the tumor microenvironment: from bench to human application","volume":"9","author":"Gabriel","year":"2018","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.suc.2019.09.008_bib79","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1200\/JCO.2013.54.2340","article-title":"Prediction of survival in patients with thin melanomas: results from a multi-institution study","volume":"32","author":"Maurichi","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.suc.2019.09.008_bib80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/CMR.0000000000000143","article-title":"The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma","volume":"25","author":"Hieken","year":"2015","journal-title":"Melanoma Res"},{"key":"10.1016\/j.suc.2019.09.008_bib81","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.5858\/2009-0653-RAR.1","article-title":"Prognostication in thin cutaneous melanomas","volume":"134","author":"Gimothy","year":"2010","journal-title":"Arch Pathol Lab Med"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610919301264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610919301264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:12:39Z","timestamp":1758539559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610919301264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0039610919301264"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2019.09.008","relation":{},"ISSN":["0039-6109"],"issn-type":[{"type":"print","value":"0039-6109"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsurgical Management of Lymph Node Basins in Melanoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}